Jean-Claude BJ - Search Results

1

Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model.

Facchin C, Fraga-Timiraos AB, Schmitt J, Babaa N, Pannu N, Aliaga A, Larroque AL, Jean-Claude BJ. Facchin C, et al. Among authors: jean claude bj. Cells. 2023 Mar 16;12(6):914. doi: 10.3390/cells12060914. Cells. 2023. PMID: 36980255 Free PMC article.

2

ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro.

Amrein L, Rachid Z, Jean-Claude B, Soulières D, Aloyz R, Panasci L. Amrein L, et al. Leukemia. 2011 Sep;25(9):1512-6. doi: 10.1038/leu.2011.110. Epub 2011 Jun 7. Leukemia. 2011. PMID: 21647162 Free PMC article. No abstract available.

3

Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine.

Wong P, Villeneuve G, Tessier V, Banerjee K, Nedev H, Jean-Claude BJ, Leyland-Jones B. Wong P, et al. J Pharm Biomed Anal. 2002 May 15;28(3-4):693-700. doi: 10.1016/s0731-7085(01)00656-2. J Pharm Biomed Anal. 2002. PMID: 12008149

4

Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy.

Matheson SL, McNamee J, Jean-Claude BJ. Matheson SL, et al. J Pharmacol Exp Ther. 2001 Mar;296(3):832-40. J Pharmacol Exp Ther. 2001. PMID: 11181914

5

Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-triazene" BJ2000, a new probe for Combi-Targeting postulates.

Brahimi F, Matheson SL, Dudouit F, McNamee JP, Tari AM, Jean-Claude BJ. Brahimi F, et al. J Pharmacol Exp Ther. 2002 Oct;303(1):238-46. doi: 10.1124/jpet.102.039099. J Pharmacol Exp Ther. 2002. PMID: 12235257

6

Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.

Matheson SL, McNamee JP, Jean-Claude BJ. Matheson SL, et al. Cancer Chemother Pharmacol. 2003 Jan;51(1):11-20. doi: 10.1007/s00280-002-0525-4. Epub 2002 Nov 22. Cancer Chemother Pharmacol. 2003. PMID: 12497201

7

The combi-targeting concept: chemical dissection of the dual targeting properties of a series of "combi-triazenes".

Rachid Z, Brahimi F, Katsoulas A, Teoh N, Jean-Claude BJ. Rachid Z, et al. J Med Chem. 2003 Sep 25;46(20):4313-21. doi: 10.1021/jm030142e. J Med Chem. 2003. PMID: 13678409

8

Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor tyrosine kinase and an alkylating agent: a novel tumor targeting concept.

Banerjee R, Rachid Z, McNamee J, Jean-Claude BJ. Banerjee R, et al. J Med Chem. 2003 Dec 4;46(25):5546-51. doi: 10.1021/jm030423m. J Med Chem. 2003. PMID: 14640561

9

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line.

Banerjee R, Rachid Z, Qiu Q, McNamee JP, Tari AM, Jean-Claude BJ. Banerjee R, et al. Br J Cancer. 2004 Sep 13;91(6):1066-73. doi: 10.1038/sj.bjc.6602098. Br J Cancer. 2004. PMID: 15365562 Free PMC article.

10

Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA.

Brahimi F, Rachid Z, Qiu Q, McNamee JP, Li YJ, Tari AM, Jean-Claude BJ. Brahimi F, et al. Int J Cancer. 2004 Nov 10;112(3):484-91. doi: 10.1002/ijc.20383. Int J Cancer. 2004. PMID: 15382076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters